I now have comprehensive data from multiple authoritative textbooks. Let me compile the complete viva Q&A.
Panophthalmitis - Complete Viva Questions & Answers
Sources: Robbins & Cotran Pathologic Basis of Disease, Wills Eye Manual (9e), Harrison's Principles of Internal Medicine (22e), Kanski's Clinical Ophthalmology (10e), Tintinalli's Emergency Medicine, Tietz Laboratory Medicine
Fig: Exogenous panophthalmitis. Eye removed after foreign body injury. Suppurative inflammation of the entire orbit has distorted all internal architecture. (Robbins & Cotran, p.1216)
Q1. Define panophthalmitis and distinguish it from endophthalmitis.
Answer:
- Endophthalmitis is inflammation of the interior of the eye involving the vitreous humor. It does not extend beyond the sclera.
- Panophthalmitis is inflammation of the entire eye - the interior (vitreous, retina, choroid) plus the sclera, extending into the orbit (peri-ocular tissues).
The key distinction: panophthalmitis is endophthalmitis that has "broken out" through the scleral coat and involves periorbital structures. It is therefore the most severe and destructive form of intraocular infection.
- Robbins & Cotran Pathologic Basis of Disease, p.1216
Q2. How is panophthalmitis / endophthalmitis classified?
Answer:
By source of infection:
| Type | Definition | Common causes |
|---|
| Exogenous | Organism gains access through an external wound | Post-surgical (cataract, vitrectomy, intravitreal injection), penetrating trauma, IOFB, corneal ulcer extension |
| Endogenous | Organism delivered hematogenously from within the body | Septicemia, bacteremia, fungemia (IV drug use, immunocompromised states, hepatobiliary infections) |
Panophthalmitis typically results from untreated or rapidly progressive exogenous endophthalmitis, or from very virulent organisms in endogenous disease (e.g., Klebsiella pneumoniae, Pseudomonas aeruginosa).
- Robbins & Cotran, p.1216; Wills Eye Manual
Q3. What are the common causative organisms in panophthalmitis?
Answer:
Post-surgical (most common overall):
- Staphylococcus epidermidis - most common post-cataract
- Staphylococcus aureus
- Streptococcal species
- Gram-negative organisms: Pseudomonas, Klebsiella, Proteus, Enterobacter, E. coli, Haemophilus influenzae
- Anaerobes (less common)
Post-traumatic / penetrating injury:
- Staphylococcus, Streptococcus, Bacillus cereus (highly virulent - associated with soil/organic matter contamination)
- Fungal species (especially with organic matter - soil, vegetable matter)
- Mixed flora
Endogenous (hematogenous):
- Klebsiella pneumoniae (invasive syndrome - especially in East Asia, associated with liver abscess)
- Pseudomonas aeruginosa - causes a fulminant panophthalmitis; severe pain, chemosis, anterior uveitis, vitreous involvement
- Candida species - especially in IV drug users or systemic candidemia
- Bacillus cereus (rare, very destructive)
Bleb-associated: Streptococcus or Gram-negative organisms.
Examiner tip: Bacillus cereus is notorious for causing rapidly destructive panophthalmitis within 12-24 hours of penetrating trauma, especially from soil-contaminated injuries.
- Wills Eye Manual; Harrison's Principles of Internal Medicine 22e, p.CNS Infections chapter
Q4. Describe the clinical features (symptoms and signs) of panophthalmitis.
Answer:
Symptoms:
- Severe, deep ocular pain (cardinal feature - more severe than endophthalmitis alone)
- Drastically decreased visual acuity (may be light perception or no light perception)
- Photophobia
- Fever, malaise (especially in endogenous cases)
Signs (anterior segment):
- Eyelid edema and erythema
- Marked conjunctival chemosis and injection
- Corneal edema, corneal ring ulcer (characteristic of virulent gram-negative organisms)
- Hypopyon (pus in anterior chamber)
- Absent red reflex
- Iris microabscesses
Signs (posterior segment):
- Dense vitritis
- Retinal inflammatory infiltrates
- Flame-shaped retinal hemorrhages ± white centers (Roth spots)
- Retinal/subretinal/choroidal abscesses
Signs indicating extension beyond globe (panophthalmitis specifically):
- Proptosis
- Restricted extraocular movements
- Periorbital edema and erythema
- Leukocytosis
With Pseudomonas specifically: fulminant course with severe pain, chemosis, decreased visual acuity, anterior uveitis, vitreous involvement, and panophthalmitis - Harrison's describes this as "the most devastating of P. aeruginosa eye infections."
- Wills Eye Manual; Harrison's 22e; Robbins & Cotran, p.1216
Q5. What investigations would you order in a suspected case of panophthalmitis?
Answer:
Ocular investigations:
- B-scan ultrasonography - to assess posterior segment when view is limited; confirms vitritis, membranes, choroidal thickening, retinal detachment; establishes baseline for treatment response
- Anterior chamber paracentesis (0.2 mL) - for Gram stain, culture (blood, chocolate, Sabouraud, thioglycolate media), and sensitivities
- Vitreous tap / diagnostic vitrectomy - more sensitive than AC tap; mandatory if visual acuity is light perception or worse
- CT orbit (axial, coronal, parasagittal views with 1-mm cuts) - especially in traumatic cases to rule out intraocular foreign body (IOFB), assess orbital extension, detect gas-forming organisms
Systemic investigations (especially in endogenous panophthalmitis):
- Blood cultures (aerobic and anaerobic) × 2 sets
- Complete blood count with differential (leukocytosis expected)
- Blood glucose, HbA1c (diabetes is a major risk factor for Klebsiella endogenous panophthalmitis)
- Liver function tests + abdominal ultrasound/CT (Klebsiella liver abscess as primary source)
- Echocardiogram if endocarditis suspected
- Chest X-ray (pulmonary source for hematogenous spread)
- Infectious disease consult
Culture media for intraocular specimens:
- Blood agar (aerobic bacteria)
- Chocolate agar (fastidious organisms, Haemophilus)
- Sabouraud dextrose agar (fungi)
- Thioglycolate broth (anaerobes)
- Gram and Giemsa stains on smears
- Wills Eye Manual; Tintinalli's Emergency Medicine
Q6. What is the treatment of panophthalmitis? Give specific drug names and doses.
Answer:
Treatment is aggressive, multidisciplinary, and time-critical. Every hour of delay risks irreversible retinal damage.
Step 1: Hospitalization
- Mandatory - patient requires IV antibiotics, close monitoring q12-24h
Step 2: Cultures before antibiotics
- AC tap / vitreous tap for Gram stain, culture, sensitivity
Step 3: Intravitreal antibiotics (most important step)
Broad-spectrum coverage - given as two injections simultaneously:
| Drug | Dose | Coverage |
|---|
| Vancomycin | 1 mg in 0.1 mL | Gram-positive (MRSA, Staph) |
| Ceftazidime | 2.2 mg in 0.1 mL | Gram-negative |
| Amikacin 0.4 mg in 0.1 mL OR Clindamycin 1 mg in 0.1 mL | alternative | Gram-negative / Bacillus / anaerobes (if penicillin allergy or IOFB) |
Caution: Aminoglycosides (amikacin) carry risk of macular infarction - use cautiously. Repeat intravitreal antibiotics every 48-72 hours as needed.
For fungal panophthalmitis: intravitreal voriconazole or amphotericin B
Step 4: Systemic (IV/oral) antibiotics
- Ciprofloxacin 400 mg IV q12h OR Moxifloxacin 400 mg PO/IV daily
- Cefazolin 1 g IV q8h
- Fluoroquinolones (moxifloxacin) achieve therapeutic vitreous levels - an advantage over many other systemic antibiotics
- Adjust for renal function and pediatric dosing
Step 5: Topical therapy
- Fortified antibiotics: Vancomycin + tobramycin q1h (around the clock for 24-48 hours) - especially if bleb, wound leak, or exposed sutures
- Atropine 1% b.i.d.-t.i.d. (cycloplegia, pain relief, prevents synechiae)
- Topical steroids (prednisolone acetate 1% q1h) - for anterior segment inflammation
Step 6: Intravitreal corticosteroids
- Dexamethasone 0.4 mg/0.1 mL - considered in severe vitreous inflammation (reduces secondary inflammatory damage)
Step 7: Pars plana vitrectomy (PPV)
- Definitive indication: Visual acuity = light perception or worse (post-cataract endophthalmitis - from EVS trial data)
- PPV reduces infectious burden, obtains material for culture, removes inflammatory mediators
- In traumatic cases: removes IOFB (paramount for infection control) and inflammatory debris
- Benefit in non-surgical endophthalmitis cases is less defined but generally recommended in panophthalmitis
Step 8: Removal of IOFB (in traumatic panophthalmitis)
- Paramount - retained foreign bodies perpetuate infection
Step 9: Tetanus prophylaxis
- Tetanus toxoid 0.5 mL IM if immunization not up to date (traumatic cases)
Step 10: Evisceration / Enucleation
- When the eye is irretrievably lost, severely painful, and there is risk to the contralateral eye (sympathetic ophthalmia) or life
- Evisceration: removal of intraocular contents, scleral coat preserved - preferred for infection control, faster, lower risk of meningitis spread in some settings
- Enucleation: removal of entire globe - indicated if tumor is suspected or optic nerve involvement
- Wills Eye Manual; Harrison's 22e; Tietz Lab Medicine, p.EYE INFECTIONS; Miller's Anesthesia
Q7. What is the Endophthalmitis Vitrectomy Study (EVS) and what did it show?
Answer:
The EVS (1995) was a landmark RCT that studied management of acute post-cataract-surgery endophthalmitis. Key findings:
- Immediate PPV is beneficial when visual acuity is light perception or worse - patients with LP or worse VA who underwent PPV had a 3-fold better chance of achieving 20/40 or better vision compared to vitreous tap alone.
- Systemic antibiotics (IV amikacin + cefazolin) provided NO additional benefit over intravitreal antibiotics alone in post-cataract endophthalmitis.
- Subconjunctival antibiotics were used in the original protocol but are now rarely used.
Important limitation: The EVS specifically studied post-cataract endophthalmitis. Its results do NOT directly apply to post-traumatic, bleb-related, or endogenous panophthalmitis - systemic antibiotics may still be important in those scenarios.
- Wills Eye Manual
Q8. What is the difference between evisceration and enucleation? When is each done in panophthalmitis?
Answer:
| Feature | Evisceration | Enucleation |
|---|
| Definition | Removal of intraocular contents; scleral shell and extraocular muscles preserved | Removal of entire globe including sclera |
| Orbital contents | EOM, orbital fat, bone preserved | EOM preserved, fat preserved |
| Indications | Blind, painful eye; panophthalmitis (most preferred); phthisis bulbi | Suspected intraocular tumor; risk of sympathetic ophthalmia; optic nerve disease; when evisceration technically not possible |
| Advantages | Better cosmetic result; lower anesthesia risk; preserves natural socket anatomy | Eliminates risk of sympathetic ophthalmia completely |
| Contraindication | Suspected malignancy | - |
In panophthalmitis, evisceration is generally preferred because:
- Faster procedure
- Better cosmesis (scleral shell preserved)
- Direct access to infected contents for drainage/culture
- Reduces septic focus
Exenteration (removal of all orbital contents including globe, fat, muscles) is reserved for orbital extension or malignancy.
- Miller's Anesthesia, 10e; Tietz Lab Medicine
Q9. What organisms cause endogenous panophthalmitis, and what systemic conditions predispose to it?
Answer:
Organisms:
- Klebsiella pneumoniae - invasive syndrome: liver abscess → hematogenous spread to eye; classically in diabetic East Asian patients; [associated with 6-year Chinese study showing high mortality - PMID 34280072]
- Pseudomonas aeruginosa - fulminant; described in bacteremia; also linked to contaminated artificial tears (carbapenem-resistant strains causing outbreaks in the USA per Harrison's 22e)
- Candida albicans / tropicalis - IV drug users, systemic candidemia, TPN patients, immunocompromised
- Aspergillus - immunocompromised, post-transplant
- Bacillus cereus - post-traumatic / IV drug use
- Streptococcus pneumoniae, S. aureus - from pulmonary or skin source
Predisposing systemic conditions:
- Diabetes mellitus (most important risk factor for Klebsiella)
- Immunosuppression (HIV/AIDS, transplant, chemotherapy)
- IV drug use (fungal/bacterial)
- Infective endocarditis
- Meningitis (Neisseria meningitidis)
- Septicemia
- Pulmonary infections
- Hepatobiliary disease (Klebsiella liver abscess)
- Total parenteral nutrition (Candida)
- Robbins & Cotran, p.1216; Harrison's 22e; Wills Eye Manual
Q10. What are the differentials of panophthalmitis?
Answer:
| Condition | Distinguishing features |
|---|
| TASS (Toxic Anterior Segment Syndrome) | Occurs 6-24 hours post-surgery; diffuse corneal edema; NO vitritis; responds to topical steroids; sterile |
| Sterile (aseptic) endophthalmitis | Follows intravitreal triamcinolone/anti-VEGF; no pain/fever; no progressive worsening; sterile cultures |
| Phacoanaphylactic inflammation | Exposed lens protein; AC reaction, KP, elevated IOP; sterile; history of lens injury |
| Orbital cellulitis | Proptosis, restricted EOM, fever; no anterior chamber reaction; periorbital signs without hypopyon |
| Acute uveitis flare | History of uveitis/HLA-B27; no fever; responds to steroids; no hypopyon typically |
| Lens particle uveitis | Post-surgical retained lens fragment; angle/vitreous particles; no organisms |
| Sympathetic ophthalmia | Bilateral granulomatous uveitis; following perforating injury; Dalen-Fuchs nodules; latency period |
- Wills Eye Manual
Q11. What is the role of steroids in management of endophthalmitis/panophthalmitis?
Answer:
Steroids play a dual role - reducing inflammation but potentially impairing immunity:
Topical corticosteroids:
- Prednisolone acetate 1% q1h - controls anterior segment inflammation, reduces secondary scarring
Intravitreal dexamethasone:
- 0.4 mg/0.1 mL - given alongside intravitreal antibiotics in severe vitreous inflammation
- Rationale: reduces cytokine-mediated retinal damage once infection is being controlled
Systemic corticosteroids:
- Oral prednisone 60 mg/day for 5 days - was part of the original EVS protocol
- Current use depends on: causative organism (avoid in fungal), patient comorbidities (caution in diabetics), severity and duration
- Once infection is sterilized, the post-endophthalmitis inflammation can be significant and should be treated aggressively
Key principle: Steroids should only be given AFTER adequate antibiotic coverage is established. Never use steroids without concurrent antibiotics.
- Wills Eye Manual
Q12. What is the prognosis of panophthalmitis, and what factors determine outcome?
Answer:
Prognosis is generally poor for visual recovery - panophthalmitis represents the most severe end of the spectrum. Key points:
Poor prognostic factors:
- Virulent organisms (Bacillus cereus, Pseudomonas, Streptococcus) - rapid destruction within hours
- Delayed presentation / delayed treatment
- Visual acuity at presentation of light perception or worse
- Traumatic etiology with IOFB
- Immunocompromised host
- Endogenous source (mortality risk from systemic sepsis)
Better prognostic factors:
- Less virulent organisms (S. epidermidis - most favorable)
- Early presentation and treatment
- Hand motion or better visual acuity at presentation
- Post-surgical rather than traumatic etiology
The retina is exquisitely sensitive: just a few hours of suppurative inflammation in the vitreous may be sufficient to cause irreversible retinal injury. This makes panophthalmitis an ophthalmic emergency.
Systemic risk: Endogenous panophthalmitis carries mortality risk from the underlying systemic infection (septicemia, Klebsiella pneumoniae syndrome).
- Robbins & Cotran, p.1216; Wills Eye Manual; Qi M et al, Semin Ophthalmol 2022 [PMID 34280072]
Q13. What is the significance of a "corneal ring ulcer" in panophthalmitis?
Answer:
A corneal ring ulcer (ring-shaped infiltrate/ulcer at the periphery of the cornea) in the context of panophthalmitis is a characteristic sign of:
- Gram-negative infection, particularly Pseudomonas aeruginosa or Acanthamoeba
- Indicates involvement of the limbal arcade and peripheral corneal stroma
- Suggests an antigen-antibody immune complex deposition mechanism at the limbus
- In Pseudomonas endophthalmitis/panophthalmitis, the disease is described as fulminant with rapid visual deterioration, fever, leukocytosis, proptosis, corneal ring ulcer, and panophthalmitis
Its presence alongside panophthalmitis signs is a grave prognostic indicator requiring:
- Immediate intravitreal + systemic gram-negative coverage
- Surgical intervention (PPV)
- Wills Eye Manual; Harrison's 22e
Q14. What is sympathetic ophthalmia and how does it relate to panophthalmitis / penetrating trauma?
Answer:
Sympathetic ophthalmia is a bilateral granulomatous uveitis that occurs after penetrating injury (or surgery) to one eye (exciting eye), affecting the other (sympathizing eye).
Mechanism: T-cell mediated autoimmune reaction against uveal antigens (melanocytes) exposed by the trauma. The uninjured eye mounts an immune response against its own uveal tissue.
Relevance to panophthalmitis:
- Penetrating trauma causing panophthalmitis is a risk factor
- To prevent sympathetic ophthalmia in a blind, painful eye, enucleation within 2 weeks of the inciting trauma was classically recommended (before the inflammatory response becomes self-sustaining)
- Once sympathetic ophthalmia has developed, enucleation of the exciting eye may not prevent progression in the sympathizing eye
Why it matters in viva:
- This is the primary reason for considering enucleation rather than evisceration - evisceration may not remove all uveal tissue and theoretically carries a (disputed) risk of sympathetic ophthalmia
- Treatment of sympathetic ophthalmia: high-dose systemic corticosteroids, immunosuppressants (mycophenolate, azathioprine, cyclosporine)
- Kanski's Clinical Ophthalmology 10e; Wills Eye Manual
Q15. A patient presents 2 days after cataract surgery with severe eye pain, hypopyon, and absent red reflex. Visual acuity is light perception. What is your management?
Answer:
This is acute post-operative endophthalmitis with VA = LP. Manage as follows:
-
Immediate hospitalization - ophthalmic emergency
-
Cultures first: Vitreous tap (0.2 mL) + anterior chamber paracentesis (0.2 mL) - Gram stain, blood agar, chocolate agar, Sabouraud, thioglycolate
-
Intravitreal antibiotics immediately:
- Vancomycin 1 mg/0.1 mL (Gram-positive coverage)
- Ceftazidime 2.2 mg/0.1 mL (Gram-negative coverage)
- ± Dexamethasone 0.4 mg/0.1 mL intravitreally
-
Immediate pars plana vitrectomy - VA = LP is the EVS threshold; PPV gives 3× better visual outcome vs tap alone
-
Topical therapy:
- Prednisolone acetate 1% q1h
- Atropine 1% b.i.d.-t.i.d.
- Fortified vancomycin + tobramycin q1h (if wound leak/bleb)
-
Systemic antibiotics: Moxifloxacin 400 mg PO/IV daily (achieves therapeutic vitreous levels) - not proven to improve outcomes per EVS, but used in severe/bleb-related cases
-
Follow up q12-24h: Relief of pain at 48h is a good prognostic sign. If no improvement at 48h - repeat intravitreal antibiotics; reassess for drug-resistant organisms or fungal etiology
-
If cultures grow organism - narrow antibiotics accordingly
- Wills Eye Manual; EVS Study reference
Summary Table: High-Yield Viva Points
| Point | Answer |
|---|
| Definition | Inflammation of entire eye including sclera extending into orbit |
| Most common organism (post-cataract) | S. epidermidis |
| Most virulent organism | Bacillus cereus (destroys eye in 12-24h) |
| Corneal ring ulcer suggests | Gram-negative (Pseudomonas) |
| First-line intravitreal antibiotics | Vancomycin + Ceftazidime |
| EVS threshold for PPV | VA = light perception or worse |
| Systemic antibiotic that reaches vitreous | Moxifloxacin |
| Endogenous panophthalmitis classic cause | Klebsiella (diabetic, liver abscess) |
| Surgery to prevent sympathetic ophthalmia | Enucleation within 2 weeks |
| Preferred surgery in panophthalmitis | Evisceration (unless tumor suspected) |
| Most sensitive sample for culture | Vitreous tap (> AC tap) |
| Steroid rule | Only after antibiotic coverage established |
| Retinal tolerance of vitreous suppuration | Only a few hours before irreversible damage |